These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25058066)

  • 1. FDA approves first celecoxib generics.
    Kuehn BM
    JAMA; 2014 Jun; 311(24):2470. PubMed ID: 25058066
    [No Abstract]   [Full Text] [Related]  

  • 2. Arthritis medicines and cardiovascular events--"house of coxibs".
    Topol EJ
    JAMA; 2005 Jan; 293(3):366-8. PubMed ID: 15623849
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA advisers endorse Celebrex for juvenile rheumatoid arthritis: lack of studies in children raises safety concerns.
    Young D
    Am J Health Syst Pharm; 2007 Jan; 64(1):11-2. PubMed ID: 17189564
    [No Abstract]   [Full Text] [Related]  

  • 4. The pain game.
    Wadman M
    Nature; 2007 Jul; 448(7152):400-1. PubMed ID: 17653159
    [No Abstract]   [Full Text] [Related]  

  • 5. Celecoxib approved as NSAID with some concessions on class warning.
    Miller JL
    Am J Health Syst Pharm; 1999 Mar; 56(5):403. PubMed ID: 10096694
    [No Abstract]   [Full Text] [Related]  

  • 6. Celecoxib shown effective in preventing colon polyps.
    Nelson NJ
    J Natl Cancer Inst; 2006 May; 98(10):665-7. PubMed ID: 16705118
    [No Abstract]   [Full Text] [Related]  

  • 7. Raising the safety bar--the FDA's coxib meeting.
    Okie S
    N Engl J Med; 2005 Mar; 352(13):1283-5. PubMed ID: 15800221
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug safety. FDA panel urges caution on many anti-inflammatory drugs.
    Couzin J
    Science; 2005 Feb; 307(5713):1183-5. PubMed ID: 15731414
    [No Abstract]   [Full Text] [Related]  

  • 9. The COX-2 inhibitors--an update.
    Furberg CD
    Am Heart J; 2006 Aug; 152(2):197-9. PubMed ID: 16875896
    [No Abstract]   [Full Text] [Related]  

  • 10. Balancing the risks and benefits of celecoxib.
    Caldwell B; Beasley R; Weatherall M; Metcalfe S
    Am J Med; 2007 Jun; 120(6):e17. PubMed ID: 17524734
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety of short-term administration of celecoxib in decompensated cirrhosis.
    Campbell MS; Makar GA
    Hepatology; 2005 Jul; 42(1):237; author reply 238. PubMed ID: 15892075
    [No Abstract]   [Full Text] [Related]  

  • 12. [Celecoxib].
    Babić-Naglić D
    Reumatizam; 2001; 48(2):27-8. PubMed ID: 12476745
    [No Abstract]   [Full Text] [Related]  

  • 13. [The growth inhibitory effect of non-steroid anti-inflammatory drugs on ovarian cancer].
    Wang HJ; Peng ZL; Liu XQ; Yang KX; Lou JY; Luo FM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 38(3):428-32. PubMed ID: 17593823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of celecoxib in patients with adverse reactions to nimesulide.
    Liccardi G; D'Amato G; Canonica GW; Lobefalo G; Noschese P; Piccolo A; Salzillo A; Passalacqua G
    Allergy; 2005 May; 60(5):708-9. PubMed ID: 15813826
    [No Abstract]   [Full Text] [Related]  

  • 15. Are COX-2 inhibitors safe for anyone.
    Bloomfeld RS
    Inflamm Bowel Dis; 2006 Sep; 12(9):922-3. PubMed ID: 16954813
    [No Abstract]   [Full Text] [Related]  

  • 16. Risks and benefits of celecoxib to prevent recurrent adenomas.
    Psaty BM; Potter JD
    N Engl J Med; 2006 Aug; 355(9):950-2. PubMed ID: 16943408
    [No Abstract]   [Full Text] [Related]  

  • 17. Amelioration of small bowel injury by switching from nonselective nonsteroidal anti-inflammatory drugs to celecoxib in rheumatoid arthritis patients: a pilot study.
    Inoue T; Iijima H; Arimitsu J; Hagihara K; Kawai S; Shiraishi E; Hiyama S; Mukai A; Shinzaki S; Nishida T; Ogata A; Tsujii M; Takehara T
    Digestion; 2014; 89(2):124-32. PubMed ID: 24526219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In brief: generic celecoxib.
    Med Lett Drugs Ther; 2014 Jul; 56(1447):59. PubMed ID: 25046416
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective use of selective nonsteroidal anti-inflammatory drugs in inflammatory bowel disease.
    Korzenik JR; Podolsky DK
    Clin Gastroenterol Hepatol; 2006 Feb; 4(2):157-9. PubMed ID: 16469674
    [No Abstract]   [Full Text] [Related]  

  • 20. COX-2 selective inhibitors--important lessons learned.
    Maxwell SR; Webb DJ
    Lancet; 2005 Feb 5-11; 365(9458):449-51. PubMed ID: 15705439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.